Movicol (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that remains largely unabsorbed in the gastrointestinal tract. It creates an osmotic gradient that draws water into the intestinal lumen, increasing stool water content, softening the feces and stimulating peristalsis to facilitate evacuation.

The dose of Movicol is individualized by the prescribing healthcare professional based on the patient’s age, severity of constipation and response to therapy. The prescriber determines the appropriate amount of powder to dissolve in water for each administration.

Safety of Movicol in pregnancy or while breastfeeding has not been definitively established. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks and benefits with their healthcare provider before using the product.

To order Movicol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Movicol (macrogol 3350) is an osmotic laxative that directly retains water in the bowel, whereas lactulose is a synthetic disaccharide that is fermented by colonic bacteria to produce osmotic acids. Movicol generally produces a faster onset of softer stools with fewer gas‑related side effects, while lactulose may be preferred for hepatic encephalopathy management.

Movicol should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the powder from moisture and direct sunlight. Keep the container tightly closed when not in use to maintain product stability.

Movicol is supplied as a powder that is dissolved in a measured amount of water, usually 125 mL, to create an oral solution. The solution is taken by mouth as directed by the prescriber, typically once daily, with or without food.

Serious risks include severe electrolyte imbalance (especially sodium or potassium disturbances), significant dehydration, and rare allergic reactions such as rash, swelling or angioedema. Patients should seek immediate medical attention if they experience symptoms like extreme weakness, irregular heartbeat, severe abdominal pain or signs of an allergic response.

Movicol should be avoided in individuals with known hypersensitivity to macrogol or any of its components, in patients with severe renal impairment, uncontrolled heart failure, or existing electrolyte disorders such as hypernatremia or hyperkalemia, unless advised otherwise by a qualified healthcare professional.